Dr. Reddy's Launches Generic Xopenex

Dr. Reddy's Laboratories announced the launch of Levalbuterol Inhalation Solution, the generic version of Sunovion's Xopenex Inhalation Solution.

Levalbuterol is a beta2-adrenergic agonist indicated for he treatment or prevention of bronchospasm in patients >6 years old with reversible obstructive airway disease. Activation of beta2-adrenergic receptors on airway smooth muscle leads to the activation of adenylate cyclase and to an increase in the intracellular concentration of cyclic AMP. Levalbuterol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles.

RELATED: Asthma Treatments: Inhalations

Levalbuterol Inhalation Solution is available in a 0.31mg/3mL, 0.63mg/3mL, and 1.25mg/3mL unit-dose vials (5x3mL) in 25-count cartons.

For more information call (866) 733-3952 or visit DrReddys.com.